China Shineway Pharmaceutical Group Limited
CSWYY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $260 | $255 | $304 | $253 |
| - Cash | $6,861 | $6,140 | $6,235 | $5,889 |
| + Debt | $341 | $347 | $351 | $301 |
| Enterprise Value | -$6,259 | -$5,538 | -$5,580 | -$5,334 |
| Revenue | $228 | $236 | – | $2,118 |
| % Growth | -3.3% | – | – | – |
| Gross Profit | $165 | $175 | – | $1,590 |
| % Margin | 72.2% | 74.5% | – | 75.1% |
| EBITDA | $118 | $50 | – | $464 |
| % Margin | 51.7% | 21.3% | – | 21.9% |
| Net Income | $85 | $30 | – | $478 |
| % Margin | 37.2% | 12.6% | – | 22.6% |
| EPS Diluted | 44.8 | 15.8 | – | 253.2 |
| % Growth | 183.5% | – | – | – |
| Operating Cash Flow | $95 | $62 | – | $611 |
| Capital Expenditures | -$14 | -$9 | – | -$95 |
| Free Cash Flow | $81 | $53 | – | $516 |